All the latest developments
from the institute

Aav Hippocampus

Gene therapy: £2m boost for a core facility at the UK DRI

Adeno-associated virus (AAV) is one of the most actively investigated gene therapy vehicles. Now, under the leadership of Prof Chris Shaw, Associate Director of UK DRI at Kings, the institute will be at the forefront of realising this potential.

Read Article
Paul Matthews Imperial

Major donation to accelerate neurodegenerative disease research at Imperial

The £1.63M gift from Lily Safra and the Edmond J. Safra Foundation will support fellowships for rising stars in Parkinson's Disease research.

Read Article
Horizon Europe Graphic

UK DRI Director, Bart De Strooper, leads call for brain science priority in Horizon Europe funding

The UK DRI has joined major European institutions in launching a petition that urges the EU to give greater emphasis to neuroscience research in its upcoming strategic and funding plan for Horizon Europe.

Read Article
Screen Brain Game

UK DRI Care Research: Take part today through online brain games!

​In this 3-minute interview with Dr Adam Hampshire, from our new Care Research & Technology centre at Imperial, we find out what he hopes to achieve and how members of the public can contribute to his research.

Read Article

UK DRI at the MRC Science Fete: Virtual Reality Lab Tours, DNA, and Brain Hoopla

On Saturday 15 June, UK DRI joined MRC units from across UCL to transform South Cloisters into a Summer Science Fete, as part of the MRC Festival. A family fun day, over 300 attendees met scientists and learnt about current research, from experimenting with ‘Quack Quack’ disease to taking a ‘cell-fie’.

Read Article
Spires Jones Fig 1

Two key genetic risk factors linked with synapse degeneration in Alzheimer’s disease

A new study led by Prof Tara Spires-Jones, UK DRI at Edinburgh, has shed light on synaptic degeneration in Alzheimer’s disease with observations that the highly implicated clusterin protein accumulates in these vulnerable structures.

Read Article
Lewy Body Dementia Pathology Bartels

Lewy Body Dementia Center Without Walls: UK DRI Fellow awarded $600K as part of a new international collaboration

UK DRI Fellow at UCL, Dr Tim Bartels, will lead one of 10 labs awarded $14M funding in total from the National Institutes of Health (NIH).

Read Article
Gabi Paper

Model behaviour: Utilising haploid embryonic stem cells for rapid and reliable disease model generation

A team of scientists, led by Dr Gabriel Balmus, Fellow at the UK DRI at Cambridge, have successfully developed a seven-week protocol for the derivation of mouse haploid embryonic stem cells, producing a fast, reproducible and versatile means for creating disease models. Moreover, this protocol can be used for the derivation of human haploid embryonic stem cells.

Read Article
Mic 1132528 1280

Testing, testing, 1, 2, 3, 4, 5: Pilot projects awarded for fresh thinking

The UK DRI is made up of people who choose to take the road less travelled, and we run schemes to encourage and reward this. This spring, we launched our ‘Pilot Studies Programme’ and today five successful UK DRI applications have been selected.

Read Article
Fltr Charley Jan Ron And Bart3 Low Res Cropped

Dementia research sheds light on safer treatments for leukaemia

An international team of researchers at VIB-KU Leuven, Belgium, the UK Dementia Institute and the Children’s Cancer Institute, Australia, have found a safer treatment for a specific type of leukemia, thanks to lessons learned from research into Alzheimer’s disease.

Read Article
2019 05 23 Queens Square

UCL research into genetic therapies for dementia boosted by £5m donation from The Sigrid Rausing Trust

A new programme to test promising genetic therapies for neurodegenerative and dementia-causing diseases such as Alzheimer’s will be launched at UCL thanks to a £5m donation by the Sigrid Rausing Trust, one of the UK’s largest philanthropic foundations.

Read Article

UK DRI Early Career Workshop on neuroinflammation – An in-depth look at our first themed event

In the first focussed ‘Theme’ event for the UK DRI, early-career researchers from across the network joined together last month (10-11 April 19) to share knowledge and insight on the topic of neuroinflammation in a 2-day workshop

Read Article
Twitter In Stream Wide  Crete Conf Group 1

Meeting report: 'Development of the dopaminergic system – from stem cells to circuits'

Co-organised by Dr Emmanouil Metzakopian, UK DRI at Cambridge, the 2019 CamBioScience conference in Crete brought together researchers to discuss recent advances and future directions in fundamental and applied developmental neuroscience centred on the midbrain dopaminergic system.

Read Article
Mallucci Copy 3

UK DRI Associate Director partners with NHS Foundation Trust for new research in Cambridge

In Dementia Action Week, a unique research group, has been launched to test promising new drugs for dementia, including one of the world’s first studies with an antidepressant that could stop the disease progressing.

Read Article
Eisai Uk Dri Colab Image

Launching: £2m collaboration with Eisai to accelerate dementia research

This first-of-its-kind industry collaboration for the UK DRI aims to deliver innovative research that translates into improvements in diagnosis, treatment and prevention of all types of dementia.

Read Article

Recording: From Academia to Industry - A Lunchtime Conversation

Are you exploring a potential career move to industry? Watch two scientists talk about their career pathway, their transition from academia to industry, pros and cons, career tips…

Read Article

UK DRI at Edinburgh Annual Symposium 2019

The 2nd Annual Symposium from the UK DRI at Edinburgh took place at the Royal Society on 30th April. PhD student Sophie Quick takes us through her highlights from the day.

Read Article

UK DRI Researcher receives prestigious Future Leaders Fellowship from UKRI

UK DRI fellow at UCL, Dr Marc Aurel Busche, has been named as a recipients of a new fellowship scheme run by UK Research and Innovation (UKRI).

Read Article

Promising Huntington’s drug trial results shared after over a decade’s work

The full results from a ground-breaking trial showing successful lowering of a toxic protein in the neurodegenerative condition Huntington’s Disease, have been published.

Read Article
De Strooper

Do ‘microglia’ hold the key to stop Alzheimer’s disease?

A research team led by Prof. Bart De Strooper, UK DRI Director, studied how specialised brain cells called microglia respond to the accumulation of toxic proteins in the brain, a feature typical of Alzheimer’s disease.

Read Article

Founding funders

Latest tweets from @UKDRI

RT @UkdriL: We have organised a mini-symposium with @QuanterixSimoa on biomarker detection using #simoa technology on the 30th of July! Com…
23 Jul 2019 12:55

RT @DementiasUK: Do data researchers know about our hub of resources for #dementia #cohort studies? It's all in here @turinginst @CLOSER_UK
23 Jul 2019 12:29